Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Azoniaspiro Compound Xvii
2. Azoniaspiro(3 Alpha-benziloyloxynortropane-8,1'- Pyrrolidine) Chloride
3. Ceris
4. Spasmex
5. Spasmo-lyt
6. Spasmo-rhoival Tc
7. Spasmo-urgenin
8. Spasmo-urgenin Tc
9. Spasmolyt
10. Trospi
11. Uraplex
12. Uraton
1. 10405-02-4
2. Sanctura
3. Spasmex
4. Relaspium
5. Spasmo-lyt
6. Uraplex
7. Sanctura Xr
8. Regurin
9. Santura
10. Trospium Cl
11. Trospii Chloridum
12. Cloruro De Trospio
13. Spasmo 3
14. Chlorure De Trospium
15. Trospium (chloride)
16. Ip631
17. Spasmoplex
18. Ip-631
19. Trospium Chloride (sanctura)
20. 1e6682427e
21. Dsstox_cid_3724
22. Dsstox_rid_77166
23. Dsstox_gsid_23724
24. Keptan
25. Azoniaspiro Compound Xvii
26. Flotros
27. As Xvii
28. Rel-(1r,3r,5s)-3-(2-hydroxy-2,2-diphenylacetoxy)spiro[bicyclo[3.2.1]octane-8,1'-pyrrolidin]-1'-ium Chloride
29. Cas-10405-02-4
30. Ncgc00167438-01
31. Ncgc00167438-02
32. Trospiumchlorid
33. Spasmed
34. Trofame
35. Trospikan
36. Trosec
37. Regurin Xl
38. Trospii Chloridum [inn-latin]
39. Cloruro De Trospio [inn-spanish]
40. Unii-1e6682427e
41. Chlorure De Trospium [inn-french]
42. [(1s,5r)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate;chloride
43. Einecs 233-875-4
44. Trospium Chloride [usan:usp:inn:ban:jan]
45. Schembl25785
46. Trospium Chloride [mi]
47. Trospium Chloride [inn]
48. Trospium Chloride [jan]
49. Chembl3084748
50. Schembl13836646
51. Trospium Chloride [usan]
52. Chebi:32270
53. Trospium Chloride [mart.]
54. Hms3656c16
55. Hms3884h08
56. Trospium Chloride [usp-rs]
57. Trospium Chloride [who-dd]
58. Bcp23426
59. Hy-b0461
60. Tox21_112442
61. 8-alpha-benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane Chloride
62. Azoniaspiro(3-alpha-benziloyloxy-nortropan-8,1'-pyrrolidine)-chloride
63. Bdbm50540489
64. Mfcd00865254
65. S2549
66. Akos015833209
67. Tox21_112442_1
68. Ac-4235
69. Ccg-268976
70. Trospium Chloride [orange Book]
71. Trospium Chloride [ep Monograph]
72. Trospium Chloride [usp Monograph]
73. Bcp0726000291
74. Sw219146-1
75. T3305
76. I11574
77. A800884
78. W-108827
79. Q27252312
80. 3alpha-hydroxyspiro(1alphah,5alphah-nortropane-8,1'-pyrrolidinium) Chloride Benzilate
81. (1s,3r,5r)-3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-8lambda(5)-azaspiro[bicyclo[3.2.1]octane-8,1'-pyrrolidin]-8-ylium Chloride
82. [(1s,5r)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-oxidanyl-2,2-diphenyl-ethanoate Chloride
83. 2-hydroxy-2,2-diphenylacetic Acid [(1s,5r)-3-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]yl] Ester Chloride
84. 3.alpha.-hydroxy-spiro(1.alpha.h,5.alpha.h-nortropane-8,1'-pyrrolidinium) Chloride Benzilate
85. Rel-(1r,3r,5s)-3-(2-hydroxy-2,2-diphenylacetoxy)spiro[bicyclo[3.2.1]octane-8,1'-pyrrolidin]-1'-iumchloride
86. Spiro (8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium), 3-((hydroxydiphenylacetyl)oxy)-, Chloride, (1alpha, 3beta, 5alpha)
87. Spiro(1-alpha-h,5-alpha-h-nortropane-8,1'-pyrrolidinium), 3-alpha-hydroxy-, Chloride, Benzilate
88. Spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium), 3-((hydroxydiphenylacetyl)oxy)-, Chloride, (1.alpha., 3.beta., 5.alpha.)
89. Spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium, 3-((hydroxydiphenylacetyl)oxy)-, Chloride, (1alpha,3beta,5alpha)-
Molecular Weight | 428.0 g/mol |
---|---|
Molecular Formula | C25H30ClNO3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 427.1914215 g/mol |
Monoisotopic Mass | 427.1914215 g/mol |
Topological Polar Surface Area | 46.5 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 553 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Sanctura |
Drug Label | SANCTURA XR is an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5). The e... |
Active Ingredient | Trospium chloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 20mg |
Market Status | Prescription |
Company | Allergan |
2 of 6 | |
---|---|
Drug Name | Sanctura xr |
Drug Label | SANCTURA XR is an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5). The e... |
Active Ingredient | Trospium chloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 60mg |
Market Status | Prescription |
Company | Allergan |
3 of 6 | |
---|---|
Drug Name | Trospium chloride |
PubMed Health | Trospium (By mouth) |
Drug Classes | Urinary Antispasmodic |
Drug Label | Trospium Chloride Extended-Release Capsules are an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, c |
Active Ingredient | Trospium chloride |
Dosage Form | Tablet; Capsule, extended release |
Route | Oral |
Strength | 60mg; 20mg |
Market Status | Prescription |
Company | Actavis Labs Fl; Apotex; Glenmark Generics; Paddock |
4 of 6 | |
---|---|
Drug Name | Sanctura |
Drug Label | SANCTURA XR is an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5). The e... |
Active Ingredient | Trospium chloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 20mg |
Market Status | Prescription |
Company | Allergan |
5 of 6 | |
---|---|
Drug Name | Sanctura xr |
Drug Label | SANCTURA XR is an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5). The e... |
Active Ingredient | Trospium chloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 60mg |
Market Status | Prescription |
Company | Allergan |
6 of 6 | |
---|---|
Drug Name | Trospium chloride |
PubMed Health | Trospium (By mouth) |
Drug Classes | Urinary Antispasmodic |
Drug Label | Trospium Chloride Extended-Release Capsules are an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, c |
Active Ingredient | Trospium chloride |
Dosage Form | Tablet; Capsule, extended release |
Route | Oral |
Strength | 60mg; 20mg |
Market Status | Prescription |
Company | Actavis Labs Fl; Apotex; Glenmark Generics; Paddock |
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21400
Submission : 2008-03-04
Status : Active
Type : II
Certificate Number : R1-CEP 2009-213 - Rev 00
Issue Date : 2016-12-05
Type : Chemical
Substance Number : 1798
Status : Valid
Available Reg Filing : ASMF |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-03-02
Pay. Date : 2017-12-15
DMF Number : 22079
Submission : 2008-10-08
Status : Active
Type : II
NDC Package Code : 46016-1041
Start Marketing Date : 2010-12-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-02-17
Pay. Date : 2023-02-15
DMF Number : 22673
Submission : 2009-03-30
Status : Active
Type : II
Certificate Number : R1-CEP 2010-040 - Rev 03
Issue Date : 2022-12-02
Type : Chemical
Substance Number : 1798
Status : Valid
Date of Issue : 2022-06-07
Valid Till : 2025-06-25
Written Confirmation Number : WC-0057n
Address of the Firm :
NDC Package Code : 66039-864
Start Marketing Date : 2009-03-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22776
Submission : 2009-05-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23929
Submission : 2010-06-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22718
Submission : 2009-04-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21171
Submission : 2007-10-10
Status : Inactive
Type : II
Certificate Number : R1-CEP 2007-272 - Rev 00
Issue Date : 2016-02-15
Type : Chemical
Substance Number : 1798
Status : Valid
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Generic US CTD
Registration Country : United Kingdom
Brand Name :
Dosage Form : TABLET
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic US CTD
Registration Country : United Kingdom
Regulatory Info :
Registration Country : Switzerland
Brand Name : Spasmex
Dosage Form : Filmtabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Spasmex
Dosage Form : Filmtabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Spasmo Urgenin Neo
Dosage Form : Drag
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Spasmo Urgenin Neo
Dosage Form : Drag
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : Uraplex
Dosage Form :
Dosage Strength : 30 Cpr Riv 20 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2024-11-04
Date Granted : 2010-01-19
Brand Name : SANCTURA XR
Patent Number : 2537103
Filing Date : 2004-11-04
Strength per Unit : 60 mg
Dosage Form : Extended Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-11-04
Date Granted : 2010-01-19
REF. STANDARDS & IMPURITIES
Trospium Chloride Related Compound A (20 mg) ...
CAS Number : 76-93-7
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1699311
Current Lot : F0J322
Previous Lot :
NDC Code :
Trospium Chloride Related Compound B (20 mg) ...
CAS Number : 63516-30-3
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1699322
Current Lot : F0J339
Previous Lot :
NDC Code :
Trospium Chloride Related Compound C (20 mg) ...
CAS Number : 3464-71-9
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1699333
Current Lot : F1J341
Previous Lot : F0J341 (31-JAN-2018)
NDC Code :
ABOUT THIS PAGE
A Trospium Chloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trospium Chloride, including repackagers and relabelers. The FDA regulates Trospium Chloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trospium Chloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trospium Chloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trospium Chloride supplier is an individual or a company that provides Trospium Chloride active pharmaceutical ingredient (API) or Trospium Chloride finished formulations upon request. The Trospium Chloride suppliers may include Trospium Chloride API manufacturers, exporters, distributors and traders.
click here to find a list of Trospium Chloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trospium Chloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Trospium Chloride active pharmaceutical ingredient (API) in detail. Different forms of Trospium Chloride DMFs exist exist since differing nations have different regulations, such as Trospium Chloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trospium Chloride DMF submitted to regulatory agencies in the US is known as a USDMF. Trospium Chloride USDMF includes data on Trospium Chloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trospium Chloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trospium Chloride suppliers with USDMF on PharmaCompass.
A Trospium Chloride CEP of the European Pharmacopoeia monograph is often referred to as a Trospium Chloride Certificate of Suitability (COS). The purpose of a Trospium Chloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Trospium Chloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Trospium Chloride to their clients by showing that a Trospium Chloride CEP has been issued for it. The manufacturer submits a Trospium Chloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Trospium Chloride CEP holder for the record. Additionally, the data presented in the Trospium Chloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Trospium Chloride DMF.
A Trospium Chloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Trospium Chloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Trospium Chloride suppliers with CEP (COS) on PharmaCompass.
A Trospium Chloride written confirmation (Trospium Chloride WC) is an official document issued by a regulatory agency to a Trospium Chloride manufacturer, verifying that the manufacturing facility of a Trospium Chloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trospium Chloride APIs or Trospium Chloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Trospium Chloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Trospium Chloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trospium Chloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trospium Chloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trospium Chloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trospium Chloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trospium Chloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trospium Chloride suppliers with NDC on PharmaCompass.
Trospium Chloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trospium Chloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trospium Chloride GMP manufacturer or Trospium Chloride GMP API supplier for your needs.
A Trospium Chloride CoA (Certificate of Analysis) is a formal document that attests to Trospium Chloride's compliance with Trospium Chloride specifications and serves as a tool for batch-level quality control.
Trospium Chloride CoA mostly includes findings from lab analyses of a specific batch. For each Trospium Chloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trospium Chloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Trospium Chloride EP), Trospium Chloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trospium Chloride USP).
LOOKING FOR A SUPPLIER?